Status:
COMPLETED
To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism
Lead Sponsor:
Institute of Liver and Biliary Sciences, India
Conditions:
Cirrhosis Related Parkinsonism
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
After successful screening of liver cirrhosis patients attending ILBS OPD for signs of parkinsonism ( tremor, rigidity or bradykinesia, any 2 of 3). Diagnosis of hepatic/cirrhosis related parkinsonism...
Eligibility Criteria
Inclusion
- Patients with cirrhosis of liver with signs of parkinsonisms
- Patients consented for the study protocol by signing the informed consent.
Exclusion
- Age \< 18 years.
- Patient s with HCC (Hepatocellular Carcinoma).
- Patients diagnosed as Wilsons disease.
- Patient who withdrew or non complaint to the study protocol.
- ALF (Acute Liver failure)
- Classical Parkinsonism
- Atypical Parkinsonism
- Pregnancy
- Hypotension
- Uncontrolled hypertension
- CAD
- Psychiatric illness
- Acute episode of Hepatic encephlopathy
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02265484
Start Date
November 1 2013
End Date
January 1 2015
Last Update
November 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Liver & Biliary Sciences
New Delhi, National Capital Territory of Delhi, India, 110070